Emory University
This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.
PRIMARY OBJECTIVE: I. To perform a first-in-human study to assess the ability of a qOBM handheld device to reliably image skin pathology in-situ and in-vivo. SECONDARY OBJECTIVES: I. Characterize a wide variety of lesions including but limited to: Ia. Malignant lesions: basal cell cancers, squamous cell cancers, Merkel cell cancer, melanoma, etc,; Ib. Non-malignant lesions: keloids, surgical scars, actinic keratosis, benign and dysplastic nevi, cysts, lipoma; Ic. Inflammatory conditions: psoriasis, eczema, alopecia, acne, wounds, etc); Id. Characterize pre and post treatment changes in the…
Inclusion Criteria: * Male or Female * Candidate with skin lesions * Signed study-specific informed consent prior to study entry * ≥ 18 years old Exclusion Criteria: * Prior surgery or radiotherapy to the area to be treated
Undergo qOBM
Undergo SOC RT
Arctuva estimate
Verify or correct the compensation shown for this listing.